361
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Patients with inflammatory bowel disease (IBD) prefer oral tablets over other modes of medicine administration

, , ORCID Icon, & ORCID Icon
Pages 1091-1096 | Received 30 Nov 2020, Accepted 02 Mar 2021, Published online: 10 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alessandro Mannucci, Ferdinando D’Amico, Ahmad El Saadi, Laurent Peyrin-Biroulet & Silvio Danese. (2022) Filgotinib for moderately to severely active ulcerative colitis. Expert Review of Gastroenterology & Hepatology 16:10, pages 927-940.
Read now

Articles from other publishers (10)

Takayuki Matsumoto, Keita Imai, Yuki Goda, Yuki Fujimitsu, Toshifumi Kajioka, Hideaki Kihara, Yuji Funaki, Shigeru Imaki & Masato Ueno. (2023) Questionnaire Survey for Inflammatory Bowel Disease Patients in Japan; A Web-Based Japan, Crohn’s Disease, Ulcerative Colitis, Patients Survey. Crohn's & Colitis 360 5:4.
Crossref
Yinfeng Zhang, Tingting Wang, Meng Sun, Yueyue Song, Xinyuan Huang, Shutian Zhang, Jun Yang & Jinfeng Zhang. (2023) Advanced Nanomedicine: Redefining Therapeutic Paradigms for Inflammatory Bowel Disease. Advanced Healthcare Materials 12:19.
Crossref
Xavier Hébuterne, Stephan R Vavricka, Helen C Thorne, Lara MacKenzie-Smith, Raphaël Laoun & Johan Burisch. (2023) Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey. Inflammatory Intestinal Diseases 8:1, pages 41-50.
Crossref
Shubha Bhat & Florian Rieder. (2022) Hypoxia-Inducible Factor 1-Alpha Stabilizers in the Treatment of Inflammatory Bowel Diseases: Oxygen as a Novel IBD Therapy?. Journal of Crohn's and Colitis 16:12, pages 1924-1932.
Crossref
Sahar Mohajeri, Saeed Moayedi, Shabnam Mohajeri, Abbas Yadegar & Ismaeil Haririan. (2022) Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease. Frontiers in Pharmacology 13.
Crossref
Gemma Burdge, Alice Hardman, Isabel Carbery, Giacomo Broglio, Dan Greer & Christian P. Selinger. (2022) Uptake of a Switching Program for Patients Receiving Intravenous Infliximab and Vedolizumab to Subcutaneous Preparations. Journal of Clinical Medicine 11:19, pages 5669.
Crossref
E H J Savelkoul, M H J Maas, A R Bourgonje, F Crouwel, V B C Biemans, N den Broeder, M G V M Russel, T E H Römkens, N K de Boer, G Dijkstra & F Hoentjen. (2022) Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn’s Disease. Journal of Crohn's and Colitis 16:9, pages 1372-1379.
Crossref
Jan Marsal, Manuel Barreiro-de Acosta, Irina Blumenstein, Maria Cappello, Thomas Bazin & Shaji Sebastian. (2022) Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Frontiers in Medicine 9.
Crossref
Jannis Holtkötter, Rita Amaral, Rute Almeida, Cristina Jácome, Ricardo Cardoso, Ana Pereira, Mariana Pereira, Ki H. Chon & João Almeida Fonseca. (2022) Development and Validation of a Digital Image Processing-Based Pill Detection Tool for an Oral Medication Self-Monitoring System. Sensors 22:8, pages 2958.
Crossref
Yan Qin, Shanshan Wang, Qiuyu Wen, Quan Xia, Sheng Wang, Guanjun Chen, Jiayin Sun, Chenlin Shen & Shuai Song. (2021) Interactions Between Ephedra sinica and Prunus armeniaca: From Stereoselectivity to Deamination as a Metabolic Detoxification Mechanism of Amygdalin. Frontiers in Pharmacology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.